Publications

Kurizaki T, Okazaki S, Sanderson SD, Colcher D, Enke CA, Tempero MA, Baranowska-Kortylewicz J. Potentiation of radioimmunotherapy with response-selective peptide agonist of human C5a. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2002. PMID: 12097469


Margaret Tempero, MD

Levy JA. HIV-1: hitching a ride on erythrocytes. Lancet (London, England). 2002. PMID: 12103280


Jay Levy, MD

Theodosiou A, Ashworth A. MAP kinase phosphatases. Genome biology. 2002. PMID: 12184814


Alan Ashworth, PhD

Witt E, Ashworth A. Biomedicine. D-Day for BRCA2. Science (New York, N.Y.). 2002. PMID: 12065747


Alan Ashworth, PhD

Small EJ, Roach M. Prostate-specific antigen in prostate cancer: a case study in the development of a tumor marker to monitor recurrence and assess response. Seminars in oncology. 2002. PMID: 12063679


Eric Small, MD

Castelli JC, Deeks SG, Shiboski S, Levy JA. Relationship of CD8(+) T cell noncytotoxic anti-HIV response to CD4(+) T cell number in untreated asymptomatic HIV-infected individuals. Blood. 2002. PMID: 12010831


Jay Levy, MD

Harris KA, Harney E, Small EJ. Liposomal doxorubicin for the treatment of hormone-refractory prostate cancer. Clinical prostate cancer. 2002. PMID: 15046711


Eric Small, MD

Hecht FM, Busch MP, Rawal B, Webb M, Rosenberg E, Swanson M, Chesney M, Anderson J, Levy J, Kahn JO. Use of laboratory tests and clinical symptoms for identification of primary HIV infection. AIDS (London, England). 2002. PMID: 12004270


Jay Levy, MD

Linker C, Damon L, Ries C, Navarro W. Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2002. PMID: 12011123


Lloyd Damon, MD

Rini BI, Small EJ. Prostate cancer update. Current opinion in oncology. 2002. PMID: 11981273


Eric Small, MD

Moasser MM, Rosen N. The use of molecular markers in farnesyltransferase inhibitor (FTI) therapy of breast cancer. Breast cancer research and treatment. 2002. PMID: 12088116


Mark Moasser, MD

Rubenstein J, Fischbein N, Aldape K, Burton E, Shuman M. Hemorrhage and VEGF expression in a case of primary CNS lymphoma. Journal of neuro-oncology. 2002. PMID: 12160141


Marc Shuman, MD

Ross RW, Small EJ. Osteoporosis in men treated with androgen deprivation therapy for prostate cancer. The Journal of urology. 2002. PMID: 11956415


Eric Small, MD

Rubenstein J, Fischbein N, Aldape K, Burton E, Shuman M. Hemorrhage and VEGF expression in a case of primary CNS lymphoma. Journal of neuro-oncology. 2002. PMID: 12160141


James Rubenstein, MD, PhD

Ko AH, Tempero MA. Current and future strategies for combined-modality therapy in pancreatic cancer. Current oncology reports. 2002. PMID: 11937010


Margaret Tempero, MD

Ko AH, Tempero MA. Current and future strategies for combined-modality therapy in pancreatic cancer. Current oncology reports. 2002. PMID: 11937010


Andrew Ko, MD

Bergsland EK, Venook AP. Shedding old paradigms: developing viruses to treat cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2002. PMID: 11980991


Alan Venook, MD

Bergsland EK, Venook AP. Shedding old paradigms: developing viruses to treat cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2002. PMID: 11980991


Emily Bergsland, MD

Chiu VK, Bivona T, Hach A, Sajous JB, Silletti J, Wiener H, Johnson RL, Cox AD, Philips MR. Ras signalling on the endoplasmic reticulum and the Golgi. Nature cell biology. 2002. PMID: 11988737


Trever Bivona, MD, PhD

Kohlwes RJ, Chou CL. A curriculum in medical economics for residents. Academic medicine : journal of the Association of American Medical Colleges. 2002. PMID: 12010725


Calvin Chou, MD